The last decade has seen a great proliferation of supervised learning pipelines for individual diagnosis and prognosis in Alzheimer's disease. As more pipelines are developed and evaluated in the search for greater performance, only those results that are relatively impressive will be selected for publication. We present an empirical study to evaluate the potential for optimistic bias in classifica-* Corresponding author * * Data used in preparation of this article were obtained from the Alzheimers Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at:
tion performance results as a result of this selection. This is achieved using a novel, resampling-based experiment design that effectively simulates the optimisation of pipeline specifications by individuals or collectives of researchers using cross validation with limited data. Our findings indicate that bias can plausibly account for an appreciable fraction (often greater than half) of the apparent performance improvement associated with the pipeline optimisation, particularly in small samples. We discuss the consistency of our findings with patterns observed in the literature and consider strategies for bias reduction and mitigation.
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ACCEPTED MANUSCRIPT pipeline researchers, as it will mean that their results will fail to generalise. If a new pipeline is introduced into diagnostic practice on the basis of upwardly biased performance estimates and it actually fares worse than the system it replaces, then there is even the potential for harm.
Selection bias is not unknown in medical imaging [11] , though the concept is often confused with the related phenomenon of overfitting. It is now common knowledge that when pipeline parameters are selected to maximise the full sample CV performance estimate, the 'optimised' performance estimate will acquire an optimistic bias [3, 9, 12] . We want to draw attention to the fact that is not only pipeline parameters (e.g., the C of support vector machines) whose selection using CV can incur bias, but entire pipeline specifications (e.g., choice of features, algorithm); when the research community collectively evaluates many pipelines on the available data and selects the best results for publication, this is directly analogous to the selection of parameters so as to maximise performance.
As such, the community should be aware of the potential of its published results to have acquired an optimistic bias.
This paper aims to assess the likely levels of selection bias in the existing results of the literature and to assess the relative importances of the key contributory factors to assist in the reduction and mitigation of bias in future. We consider the extent to which bias may be responsible for the improvements in classification performance observed with pipeline optimisation. Because selection bias is intimately related to the role of chance in determining the ranking of pipelines' CV performance estimates, we also consider the reliability of CV experiments in determining which of two pipelines is superior. To the best of our knowledge, no other study that has attempted to do this for either AD classification or any other application of supervised learning in neuroimaging.
Before we describe our experiment and its implications, we shall first provide a clear definition of selection bias and its relationship to overfitting.
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Background
This section is concerned with providing a clear definition of selection bias and describing the mechanisms by which it may arise in AD classification research.
The performance of a pipeline
In this work, we are interested in the performances of pipelines themselves, rather than the performances of the fully specified prediction rules they produce.
For the sake of simplicity, we define the performance of a pipeline to be the expected performance measurement obtained in the cross validation experiment being used, where the expectation is taken over many independent samples.
This definitions allows us to separate concerns related to changes in training set size from those related to selection bias. For our purposes, in the absence of selection, CV performance estimators are by definition unbiased.
Introducing selection bias
The use of CV to select a high performing pipeline is directly analogous to the use of a single validation set to select a prediction rule (e.g., a regression curve) [10] . In both cases, some noisy in-sample performance estimate based on a finite sample (e.g., CV accuracy measurement, in-sample mean squared error) is used to approximate the true out-of-sample performance on a larger population of items (e.g., true pipeline performance, expected mean squared error). There is some pool of candidate pipelines/rules, from which the one with the best in-sample performance estimate is selected. In rule selection, the size of this pool is often described by "model complexity" [9] .
The performance measurement for each candidate may be regarded as the sum of its true, out-of-sample performance plus a zero-mean random effect.
Where random effects play a role in determining the empirical ranking of the pipelines by their in-sample performance estimates, the highest in-sample performance estimate is more likely to be associated with a positive random effect.
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been 'lucky' in the validation experiment.) As a consequence of this, if the validation is repeated on an independent sample, the pipeline selected as the best in the first experiment will, on average, perform worse. The expected drop in performance is the selection bias. The term 'selection bias' was first used in the context of prediction rule selection in [13] . It was borrowed by [10] to describe the related phenomenon in pipeline selection. Selection bias may be considered a form of, or analogous to, the publication bias seen in group difference studies and clinical trials [14, 15] , as it describes the inflation of effects due to selective reporting.
Selection bias is related to, but distinct from, the related phenomenon of overfitting. Overfitting properly describes the situation where a pool of candidate pipelines/prediction rules considered for selection is expanded to provide more potential for improvement, but where this expansion actually leads to the selection of a candidate with an inferior out-of-sample performance than was the case before the expansion [10] . This may be contrasted with selection bias, which is simply the expected difference between the in-sample and out-of-sample performances associated with a selected candidate. As illustrated in figure 1, while selection bias is necessary for overfitting, it also occurs in regular 'fitting'. 
Origins of selection bias in AD classification
Naked "double-dipping", or the reporting of the in-sample performance estimate after it has been used to select continuous pipeline parameters (e.g., support vector machine regularisation), has long been recognised as unacceptable practice [9, 12] . However, it is not only pipeline's parameters whose selection may introduce bias, but whole pipeline specifications (e.g., choice of features, algorithm). While published works often proceed as if each new pipeline was fully specified in complete isolation from the data, this is often likely to be a fiction; in practice, because data are limited, research groups will inevitably This may be contrasted with overfitting (i.e., deterioration in the out-of-sample performance), which only occurs once the number of candidates exceeds some optimal value. reuse subjects as they evaluate sequential pipelines ideas. Years after proof of concept, new AD classification pipelines are only likely to be of widespread interest if they deliver improvement over state-of-the-art alternatives, and relatively unimpressive results are unlikely to appear in new publications. While some of the selection may occur through the rejection of manuscripts in review, the situation is likely to be more similar to that seen in clinical research, where the most common reason that unimpressive (non-significant) results go unpublished is that they are never even submitted for publication in the first instance [14] .
Selection can occur not only at the level of an individual research group, but at the level of an entire research field. The large collections of imaging data required for AD classification experiments are far too costly for each new study to reproduce. These are expensive and time consuming to produce, so it is not possible for each new study to use a new, independent dataset. Instead, studies typically draw data from large, open access repositories of the type provided by ADNI [7] . Indeed, in recent years, the vast majority of AD classification studies have used overlapping subsets of the ADNI dataset [3, 6] . Where studies share data, they also share some of the random effects in CV performance estimation. This makes it possible for uncharacteristic performance results with large
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random effects, such as those produced by extensive selection, to be repeatable across independent studies. As the research community collectively evaluates new pipelines on the shared dataset to select the best for publication, it simulates the bias producing behaviour of the individual research group. This is the second challenge identified by Nowotny in [16] 1 , who primarily considers classification in the MNIST dataset. It is recognised in the design of the Kaggle machine learning challenges 2 , where it is dealt with by using a second validation dataset that is kept hidden until the end of the challenge.
Materials and methods
The organisation of the materials and methods is as follows: in section 3.1, we describe the ADNI subjects and images we used; we then describe how we build our pipelines in section 3.2 and the design of our experiments in sections 3.3 and 3.4.
Subjects and imaging data
All imaging and clinical data were obtained from the ADNI database. A detailed description of them is provided in Appendix A. In this study, we use T1-weighted structural magnetic resonance images from the baseline timepoint alone. This is the most commonly encountered imaging setting in AD classification research [3, 6] , in part because it is one of the most easily achievable in clinical practice. Each image underwent the full pre-processing offered by ADNI for the relevant scanner type. This includes corrections for distortions due to gradient non-linearity (GradWarp) and corrections for additional image intensity non-uniformities (B1 correction and N3 histogram peak sharpening).
Phantom-based spatial scaling was applied to all images. We conducted our own quality control assessment in addition to that provided by ADNI to cover subjects for whom no quality assessments were available. Where back-to-back 1 who uses 'overfitting' in a colloquial sense to indicate the mere presence of selection bias 2 https://www.kaggle.com/
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images were available for the baseline time-point, the one with the superior quality score was selected.
The use of structural MRI alone allows us to have a larger total sample, something that is particularly important to us because our experiment design limits us to using less than half of the full number of subjects in a single CV experiment, and we wish to retain realistic sample sizes for that step. To further increase the size of our sample, we included images from both 1.5 and 3.0 Tesla scanners. This is not unprecedented [17, 18] , and it may be a sensible option for future diagnostic tools in clinical practice where the losses in performance due to heterogeneity may be outweighed by the gains due to increased training sample sizes [17] . The inclusion of different field strengths may introduce small systematic differences between the representations of disease groups when they contain different proportions of images derived from each field strength, but we believe these should be negligible in our case (see section 5.3).
Suitable baseline images were available for a total of 1437 subjects, and all of these underwent processing. For the purposes of this study, MCI subjects were considered stable if they had an assessment up to or beyond the subsequent 24 months follow-up period in which they were not given a diagnosis of AD. MCI subjects were considered progressive if they were given a diagnosis of AD at any point during the follow-up period. MCI subjects whose progression status could not be determined were excluded from the sample used for experiments.
Subjects with suspected dementia aetiologies other than AD were excluded from our classification experiments. This yielded 372 HC subjects, 252 AD subjects, 230 stable MCI subjects (MCIs) and 135 progressive MCI subjects (MCIp).
Further image processing
A sample specific group template was created using iterative affine and then B-spline registration using the publicly available NiftyReg package 3 . Tissue segmentation and atlas propagation algorithms (more details in sections 3. 
Pipelines
Due to the constraints of implementation and computational time, it would not have been possible for us to include many of the highest performing classification pipelines from the literature. Instead, we have tried to produce a large but plausible set of pipelines based on pairings of one of the 48 feature sets described in 3.2.1 and one of the 6 classification algorithms described in 3.2.6.
Because one of the algorithms (random forest) cannot be combined with 24 of the (kernel-based) feature sets, there are 264 pipelines in total.
Feature sets
We produce our 48 features sets in the same combinatorial way that we produce our pipelines. Each feature set is a combination of some imaging descriptor (see section 3.2.2), one of two anatomical parcellation schemes to interpret that descriptor (section 3.2.3), and some way of using that scheme to perform a knowledge-based feature selection (section 3.2.4). All imaging descriptors were produced using no more than one of the two grey matter (GM) tissue concentration maps (see section 3.2.2) and one of two anatomical parcellation schemes (see section 3.2.3). Note that not all combinations of options were possible.
Imaging descriptors
GM concentration maps are one of the most fundamental tools for the study of structural changes in the brain; they have a key role in the voxel-based morphometry that has become the established tool for group difference studies in structural neuroimaging. They were the first image descriptors considered for AD classification [4] , and they are still studied frequently [18, 19] . Where we do not use GM concentrations to produce descriptors, we use the volumes of whole anatomical regions as descriptors themselves. Though these are used
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less often than GM measures, these also provide a straightforward description of brain atrophy that can be used to classify neurological diseases [20] .
We can divide the imaging descriptors into two groups: primal descriptors
representing the values of a quantity in each region of an anatomical parcellation in the native space, and dual or kernel descriptors represented by kernel matrices computed from voxelwise intensity scores in the groupwise space.
Primal descriptors. Regional GM loads were calculated by summing tissue concentrations over regions of the anatomical parcellations in the native space multiplied by the volume of the voxels. This produces descriptors that reflect changes in both the volume and concentration of GM. All GM loads were normalised for intra-cranial volume measured as the union of the white matter, GM and cerebro-spinal fluid tissue maps produced by SPM.
SPM GM loads. We use the publicly available SPM12 package 4 to provide tissue concentrations maps.
GIF GM loads. The geodesic information flow (GIF) algorithm [21] used to produce the Neuromorph parcellations (see section 3.2.3) jointly estimates various tissue concentrations maps. We included the resulting GM maps as an alternative to those of SPM.
Anatomical region volumes. The volumes of anatomical regions were normalised by intra-cranial volume.
Kernel descriptors. All kernel descriptors were produced from either GIF or SPM GM maps after transformation to the groupwise space. Kernel matrices were computed separately for each region of the group parcellation and then later combined by summation. There were three levels of further processing possible in the groupwise space, producing a total of six kernel descriptors.
1.
No further processing as the simplest option.
Modulation by the Jacobian determinant of transform from the native to the groupwise space.
3.
Smoothing (performed in addition to modulation) using an isotropic Gaussian kernel of 2.0 mm standard deviation (4.7 mm FWHM). This aims to compensate for registration errors and the spatial variation of atrophy patterns. The use of 2.0 mm was intended to be a middle-of-the road choice.
Anatomical parcellation schemes
Due to its impact on the features produced, the choice of anatomical parcellation scheme can be an important determinant of a pipeline's performance [18] .
We include two parcellation schemes in our feature sets. These were chosen because they were the only ones for which we were able to obtain the sets of manually labelled images necessary for reliable atlas propagation [21] .
Hammers. This is a scheme of 83 regions described in [22, 23] , with 30 manually labelled reference images available online 5 . The labels of these images were propagated to the space of our images and fused using the STEPS algorithm [24] .
Neuromorph. This is a scheme of up to 141 brain regions provided by the commercial company Neuromorphometrics, Inc. under academic subscription.
We use 35 labelled reference images originating from the OASIS project that were made available for the MICCAI 2012 Grand Challenge and Workshop on Multi-Atlas Labeling 6 . These were propagated and fused using the GIF algorithm [21] .
Each scheme offers a competing definition of what precisely constitutes an
anatomical region in the brain. This in turn determines which areas of the brain will be used in predictive modelling. A notable difference between the
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two schemes is the way in which cortical regions are defined. In the Hammers scheme, many regions combine both the relevant cortical grey matter and the cerebral white matter beneath. By contrast, in the Neuromorph scheme, cerebral white matter and cortical grey matter are held in separate compartments.
Spatial restriction/feature selection
The selection of relevant features can be used to remove variability in the data unrelated to the class discrimination problem. Knowledge-driven feature selection techniques have been shown to be superior to data-driven ones [25] , and they have the added advantage of being computationally inexpensive. We consider two types of spatial restriction that implement a knowledge-driven feature selection.
A symmetry constraint enforced by combining, as an average, each pair of features related to a brain region occurring in each hemisphere. While the atrophy associated with AD may not be symmetric [26] , the modes of atrophy that are most informative for classification may be. Due to the difficulty establishing a voxel-to-voxel correspondence between the hemispheres, the constraint was not applied to kernel-based feature sets.
An exclusive focus on the temporal lobes justified by their well established role in AD [27, 28] .
Zero, one, or both of these were applied to produce a feature set.
Standardisation
All kernels were scaled so that the median inter-point distance in the whole sample was one. This scaling is mentioned because of its interaction with the C parameter in the SVM algorithm (see section 3.2.6). All primal features were standardised by subtraction and division to ensure a zero mean and a unit variance.
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Classifier algorithms
Unless otherwise stated, all classifier algorithms were implemented in C++ by the authors.
SVM. The support vector machine (SVM) is the workhorse of neuroimage classification research [2, 29] , and is by a wide margin the most studied algorithm in applications related to AD [6] . We use the publicly available libsvm package [30] with a linear (precomputed) kernel, as is commonly preferred for the high dimensional classification problems of neuroimaging [2] . The C parameter was selected from the values 2 −2 , 2 −1 , · · · , 2 4 using nested two-fold CV with five repeats. Results in preliminary experiments were essentially identical if the range of C values considered was expanded.
RF. The random forest (RF) classification algorithm is based on an ensemble of decision trees [31] . RF has been applied in AD classification [6, 32] , as well as elsewhere in neuroimaging [29] . We follow the original specification by Breiman [31] with the parameter mtry set to the rounded square root of the number of features. We used 100 trees. Increasing this number in preliminary experiments produced essentially identical results. As we know of no established way to apply RF to kernel features, combinations of the RF algorithm and kernel feature sets do not appear in our final set of pipelines.
LDA1. Linear discriminant analysis (LDA) classification has been used frequently in AD classification [3, 6] , though less often than SVM. LDA is based on the projection of the data onto a single direction chosen to maximise the ratio of the between-class variance to the within-class variance.
This variance is estimated using the assumption that the distributions of both classes have identical variance. For primal feature sets only, the Ledoit-Wolf lemma [33] was used to provide a shrinkage estimator of the covariance. The threshold used for classification was based on a Gaussian model using class prior probabilities derived from the training set.
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LDA2. This is an alternative version of LDA where the full sample covariance matrix is used, rather than the sum of the covariance contributions from each of the subject groups. This produces a biased, but slightly more stable estimator of the covariance. We have found this to fare better than LDA1 in synthetic high dimensional problems.
NC. The nearest centroid (NC) algorithm can be seen as something of a 'control' for the more complex linear methods (LDA,SVM), as comparison will
show how important the estimation of the covariance structure is. This algorithm assigns unseen points the class whose distribution has the closest centre as estimated using the training data. 
Cross validation and performance measurement
We consider repeated stratified K-fold CV as an estimator of pipeline performance. The numbers of subjects that appear in each fold are determined exactly as in the publicly available libsvm package [30] . By R×Kcv, we denote K-fold CV with R repeats.
The performance measure from a single repetition of K-fold CV is assessed using the classification accuracy, defined as the fraction of subjects correctly classified. This is probably the most commonly reported performance metric for AD classification [3, 6, 19] .
. Resampling experiment design
In order to estimate the bias associated with selection of pipelines based on performance, one needs to obtain both biased and unbiased performance estimates. To do this, we use the resampling design described in figure 2 and defined below. This process is repeated 2000 times using different random partitions into left and right subsets, and the bias estimates are averaged together to provide greater stability.
We use this design to investigate two classification tasks: the discrimination of subjects with AD from healthy controls (henceforth, AD detection), and the discrimination of MCI subjects who went on to progress to AD in a 24 month interval from those who did not (henceforth, MCI prognosis). Both tasks are conducted in samples containing only the two subject classes to be discriminated. In order to investigate the effects of sample size and CV strategy, we repeat this experiment procedure many times while varying these parameters. When We investigate the effect of the number of pipelines considered on selection bias. The probability of the pipeline obtaining the rank p out of n (with p = 1 denoting the lowest performance) being ranked the highest out of κ pipelines selected randomly without replacement is
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By using this formula to combine the biases associated with all n ranks, we are able to measure the average in-sample and out-of-sample performance associated with the best performing pipeline over all n κ possible pipeline subsets. We measure the progress associated with increasing the pool of candidate pipelines as the change in performance when moving from a subset of a smaller size t one of a larger size. The change in in-sample performance is the apparent progress anticipated based on a naive interpretation of results, while the change in the out-of-sample performance is the true progress expected on independent data.
Decision power and representative variance
Selection bias is intimately related to a CV experiment's ability to correctly identify the best of several pipelines. We produce two summary measures to assess the ability of an experiment to do this.
The first measure is the decision power, defined as the posterior probability that an experiment correctly ranks a pair of pipelines. This is measured as the fraction of times that the in-sample performance ranking of a pair of pipelines was the same as the 'true' ranking based on the performance in all experiments, conditional on the absolute difference in in-sample performance estimates falling into a certain interval. This was averaged over all 264 2 pairs. It was intended to help answer the question "What is the probability that pipeline A is actually better than pipeline B, given that pipeline A performed X% better in a CV 
Results
Where the curves of multiple sample sizes appear in the plots of this section, these have been selected to display a representative range of behaviours. Where a single CV strategy is presented, this is 4×6cv. This was chosen for its relatively low bias and its intermediate fold number relative to the other strategies considered. Where both in-sample and out-of-sample accuracies are presented, the former is biased, while the latter can be regarded as accurate.
Accuracy of pipelines
We obtained a wide range of average pipeline performances in each combination of task, sample size, and CV strategy. We report the mean accuracies observed using 4×6cv and the maximum possible sample size for each task, as this produces the configuration most typical of the literature. For AD detection experiments on 300 subjects, the average performances of the pipelines spanned the range 70-90%. For MCI prognosis experiments on 300 subjects, the average performances spanned the range 60-70%. These accuracies are towards the lower end of the spectrum of published results [3, 6, 7, 34] . A more detailed description of these mean performance results is presented in Appendix B. As expected, both in-sample and out-of-sample performance increase with rank 7 . The change in the in-sample performance is greater, as the lower and higher ranks are respectively associated with negative and positive selection biases. While higher performing pipelines are, on average, better than lower performing pipelines, the magnitude of the difference is exaggerated by the insample performance estimates. In AD detection, the exaggeration is relatively small, and the majority of the observed difference in in-sample performance is due to differences in the true, out-of-sample performance. In MCI prognosis, the majority of the difference is due to selection bias; for example, when using 160 subjects, the in-sample difference between the highest and lowest performing pipelines was on average roughly 16%, the out-of-sample difference between the two was on average only roughly 6%.
Effect of rank on bias
It can be seen that smaller samples increase the magnitude of the bias at all ranks. This effect is large enough to mean that the highest in-sample performance in MCI prognosis is higher when using 50 subjects than when using 7 The in-sample performance estimates are themselves used to determine the ranks. If the out-of-sample performance estimates did not also increase with rank, this would mean that poor performance in a CV experiment was indicative of good performance in future experiment repetitions. In figure 6 , we present the relationship between sample size and the performance of the highest ranking pipeline. It can be seen that, through its effect on training set size and better pipeline selection, larger samples lead to higher true, out-of-sample performance. While this improvement will to some degree be re- This is the probability that pipeline B is truly superior to pipeline A, given that B performed X better than A in CV experiment, where X is the value of the x-axis. Horizontal bars represent calculation intervals. For i ∈ {1, 2, ..., 20}, interval i contains difference d when This was calculated as the lower end of the first interval to have a sufficiently high decision power. If one was not found, no point is plotted. It can be seen that low variance CV strategies and larger samples reduce the required difference. We found these minimum magnitudes required to produce a reliable
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Real and apparent progress in pipeline optimisation
(i − 1) < 100|d| ≤ i.
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ranking surprisingly large. If they are representative of the field, they highlight the importance of gathering a large sample before any pipelines are compared.
We note that significantly larger observed performance differences are needed to reliably rank pipelines in MCI diagnosis than in AD detection. 
Comparison with literature
The nature of selective reporting makes it difficult to assess the level of bias in the literature directly. One exception to this is found in challenges such as CADdementia [19] , which report both biased in-sample performance estimates and unbiased out-of-sample performance estimates. As can be seen in figure   7 of the relevant paper [19] , all 29 contestants overestimated the accuracy of their submitted AD classification predictors, with an average bias of almost 20% accuracy. Though it was not based on AD classification, a similar pattern is apparent in the MICCAI 2014 machine learning challenge 8 , where all but two of the 48 submissions overestimated their performance. It should be noted
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that selection bias may be greater in challenges than in standalone studies, as researchers may be less concerned about reporting biased performance estimates where they know there will be an independent validation.
As seen in figure 6 , selection bias can introduce a paradoxical effect where smaller sample sizes are associated with higher estimated performance. Larger sample sizes should allow for larger training sets, meaning that they should be associated with greater performance [25, 35] ; if a negative association is observed, this may be taken as evidence of selection bias. This provides us with a way to look for selection bias in the AD classification literature. This is analogous to the use of funnel plots to detect publication bias in group difference studies [36] .
To provide us with a representative set of reported AD classification results, we selected those from the recent review of Arbabshirani et al. [3] (see table 2 of that paper). We selected only those papers which advanced new methods (and thus excluded comparative studies such as [34] ), and considered results for AD detection and MCI prognosis. In order to avoid performing additional selection ourselves, where a range of accuracies is reported, we took the mean of the upper and lower estimates. Multi-modal studies tend to be associated with smaller samples and higher performance. In order to avoid a spurious effect due to smaller samples being associated with more informative modalities, we included only those results achieved using structural MRI alone. This yielded 55 performance estimates for AD classification and 15 for MCI prognosis. These are presented in figure 11 .
We conducted a one-sided test to assess the evidence against a non-negative association. Because a Gaussian null hypothesis is not appropriate, we used Spearman's correlation coefficient, rather than Pearson's. We observe a negative correlation in both AD detection and MCI prognosis. While the negative correlation is of greater magnitude in MCI prognosis, it only reaches significance in AD detection, due to the larger number of studies. We note that our test is somewhat conservative, as the null hypothesis of no selection bias actually corresponds to a positive rank association, rather than the zero rank associa- tion used in significance testing. We conclude that there is tentative evidence of selection bias in the AD classification literature.
Discussion
We have provided the first empirical demonstration of selection bias in AD classification. While we saw no true overfitting, our results demonstrate that bias can account for significant fraction of the apparent progress associated with pipeline optimisation (see figure 8 ). In small samples and MCI prognosis experiments, the fraction of progress attributable to bias was normally greater than 50%. The potential existence of such great bias should be of significant concern to researchers, as pipelines brought into clinical practice on the basis of overly optimistic results may lead to poor outcomes.
Controlling selection bias and mitigating its effects
Selection bias is principally controlled by variance in performance estimation and the number of pipelines considered for selection (see figures 4 and 7). Selec-
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tion bias may be reduced by using low variance CV strategies. We recommend that a large number of K-fold CV repetitions be used where computationally feasible. We recommend against the use of high variance strategies such as leave-one-out cross validation (LOOCV) (which is still used [37] [38] [39] [40] [41] ). Instead of using high numbers of folds, one can use a lower number of folds with a higher number of K-fold CV repetitions to produce a lower variance, lower bias CV strategy at equivalent computational cost (see figure 5 ).
Maximising sample size is also important for the avoidance of selection bias;
selection bias is roughly proportional to the inverse square of the sample size (see figure 5 ). This is likely due to its effect on variance. We caution against any optimisation or comparison of pipeline specifications in small samples, as this is unlikely to produce reliable identification of superior pipelines (see figures 9 and 10), and most of the apparent progress will be due to bias alone (see figure 8 ).
Though it would be cumbersome to implement, a selection bias free validation strategy does exist: one can treat the entire specification of a pipeline the same way one treats a continuous pipeline parameter, and select it using nested cross validation [10] . While this provides an unbiased answer to the question "how well can we predict?", it may not provide an answer to the question "what is the best way to predict?" Outside of this, another valuable source of bias free results comes from classification challenges such as the recent CAD-Dementia [19] . Not only do challenges provide unbiased performance estimates for individual pipelines, but they can also offer an unfiltered overview of the full distribution of the performances of evaluated methods that may be contrasted with the literature. We note that if the best result in a challenge is selected, this reintroduces the potential for bias [16] .
It is not only important that future studies work to minimise bias; the potential for bias must also be considered in the interpretation of previous published results. This is particularly the case where a result is linked with one of the following risk factors:
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• the classification task is difficult (consider MCI prognosis versus AD detection);
• the sample used to demonstrate CV performance results is small; or
• there is evidence indicative of extensive selection; for instance, there are many adjustable settings in a pipeline, and there is not clear explanation for how they have been chosen.
That MCI prognosis is particularly susceptible to bias is troubling, as AD classification pipelines are primarily justified for the superior performance they are ultimately supposed to offer in that task. There are a number of other consequences of these considerations. For instance, practitioners may prefer simpler pipelines with fewer adjustable parameters over more complex alternatives, even when the latter come with higher reported performance. Furthermore, while it might be assumed that the apparent advantage of pipelines using alternative modalities instead of or in addition to structural MRI is due to additional information in the features, it is possible that some of it may be explained by the greater potential for selection bias afforded by the smaller samples available for validation.
Particularly susceptibility of AD classification to selection bias
AD classification is not unique among other applications of supervised learning to neuroimaging in being liable to bias, but there are good reasons why it may be particularly susceptible. The great societal cost of AD provides a strong incentive for pipeline optimisation, and the availability of open access datasets has made it considerably easier for researchers to contribute. As a consequence of this, the number of published pipeline specification is already in the hundreds [5] , making it comparable to or greater than the size of a typical sample [3] . While a larger number of pipelines specifications (combinations of pre-processing, feature selection, classification algorithm) considered for selection creates more potential for genuine performance improvement, it also creates more potential for bias.
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Limitations
We do not provide a perfect simulation of the AD classification research field, as this would be technically infeasible; as such, our results should be interpreted as indicative rather than exact. Due to the difficulty in accurately determining and then implementing the full set of published research methods (registration, segmentation, feature selection, etc.) we have instead opted for a more limited set of relatively simple methods that nonetheless loosely representative of the field. Despite this, we still believe that our results are representative, and we do not anticipate that small changes to the precise combination of pipelines and CV strategies used would produce qualitatively different results. We note that while the number of pipelines considered for selection was large, it does not exceed the number of those already published [5] . While the ranges of sample sizes considered do not include some of the largest numbers seen in recent studies, they still include those seen in the majority of AD classification studies [3] .
We note that most of the metrics provided here (e.g., selection bias in a particular experimental setting) do not come with measures of measurement uncertainty. To produce these would require a deep statistical model of the distribution of results produced in our experiment, including a generative model for the distribution of subject representations in features space. We note that the same is currently lacking for even straightforward K-fold cross validation [42] .
This should not be a great concern, however, as the deviations due to randomness in our sample are likely to be smaller than those associated with changes in precise definitions of pipelines and experimental settings.
Variations in the field strength used to produce a T1-weighted image can have a subtle effect on the tissue concentration maps and region volumes derived from it. In comparative studies where subject groups contain different proportions of images from 1.5 and 3.0 Tesla scans, this may introduce spurious differences that are unrelated to physiology. Though this effect is likely present in our study, we do not think it is significant. The fraction of images acquired at 3.0 Tesla was relatively constant (between 31 and 48%) across disease groups (i.e., HC, MCIs, MCIp, and AD). Furthermore, field strength-related differences
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in tissue concentrations and volume measures will be small compared to those related to atrophy, and so seem unlikely to provide significant improvements to classification accuracy. Indeed, we did not observe any unusually impressive results suggestive of such improvements. Finally, we again note that our classification experiments do not need to precisely match the field to be informative.
Population shift
We note that selection bias is distinct from the problem of population shift (or drift) [43] , which occurs when the feature representations of the subjects to be classified in the real application of a pipeline have a different distribution to that of those used in the validation sample. This is also likely to be a great challenge in the clinical translation of AD classification methods, as they must generalise to scanner types and patient populations that may be unlike those in research settings [17] , but it is separate from the issues addressed here.
Conclusion
We have demonstrated that selection bias can plausibly account for a considerable fraction of the progress associated with pipeline optimisation in AD classification. We remind classification researchers to be aware of the potential for bias in their own work. Specifically, we encourage researchers to use low variance (low K, high repetition) cross validation strategies, and caution against pipeline optimisation or comparison before sufficiently large samples are available, as this will quickly produce misleading performance results while providing little real improvement. We also urge caution in the interpretation of published results; for MCI prognosis in particular, our results suggest that typical sample sizes provide great potential for bias. Before any published pipeline is considered for use in clinical decision making, it is imperative that the potential for selection bias be taken into account. Finally, our results highlight the importance of classification challenges, which offer a rare opportunity for the non-selective reporting of performance results.
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While this study focused on AD classification, selection bias is a potential problem for many similar applications of supervised learning in medical imaging.
Our results may be useful to researchers in other applications, as the determining factors and possible solutions are likely to be the same. Though we present them primarily to demonstrate the plausibility of our methods, we can also make some comments on the accuracies observed. These span a wide range in both tasks, with those in AD detection spanning the range 70-90%, and those in MCI prognosis spanning the range 60-70%. This is towards the lower end of the spectrum of published results [3, 6, 7, 34] .
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A loose hierarchy of classifier algorithms is evident in the AD detection task, with SVM, LDA and RF consistently performing better than Centroid and KNN with a given feature set. This is not so much the case for MCI prognosis, where the ranking of algorithms is highly dependent on the feature set. This may be due to the more difficult nature of the task confounding the fitting of more • Bias accounts for much of the performance improvement seen with pipeline optimisation.
• Assessment of key risk factors and guidance on best research practices.
• Evidence of selection bias in results collected by a recent literature review.
